title: Reduction of drug leakage by negative-balance isolated pelvic perfusion: correlation between leakage and in-out flow rate in a pig model.
abstract: OBJECTIVE
  Isolated pelvic perfusion (IPP) therapy exposes target tissues to high doses of anticancer drugs with low systemic concentrations, but the major drawback is drug leakage into the systemic circulation, which often thwarts the increased drug concentration. In this study, the efficacy of altering the in-out flow rate during IPP in order to decrease the leakage was assessed in adult pigs.
  
  
  METHODS
  The abdominal aorta and the infrarenal vena cava were occluded with two balloon catheters, blood in the extracorporeal circuit was circulated with twin rotary pumps, and the IPP was performed with platinum. Three sets of in-out flow rates were used, and the degree of drug leakage into the systemic circulation was evaluated. The volume of blood withdrawn was equal to the volume returned (300 ml/min; group A), 5% higher (group B), or 10% higher (group C). The platinum concentrations in the pelvic circulation, systemic circulation, and urine were measured and compared.
  
  
  RESULTS
  The average and maximum plasma platinum concentrations in the pelvic circulation did not significantly differ among the three groups. The plasma platinum concentrations in the systemic venous circulation of the three groups significantly (P<0.01) decreased as the volume withdrawn during IPP increased. The percentage of platinum eliminated in the urine during IPP was significantly (P<0.01) lower in group B and C than in group A.
  
  
  CONCLUSIONS
  Setting the volume withdrawn higher than the volume returned decreased leakage into the systemic circulation under isolated pelvic perfusion.
authors.affiliation: Department of Radiology/Center for Advanced Medical Technology, Nippon Medical School, 1-1-5 Sendagi, Bunkyou-ku, Tokyo, 113-8602, Japan. murata_satoru@nms.ac.jp
authors.forename: Satoru
authors.initials: S
authors.lastname: Murata
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Tajima
authors.forename: Gen-ichi
authors.initials: G
authors.lastname: Kusakai
authors.forename: Tatsuo
authors.initials: T
authors.lastname: Kumazaki
authors.forename: Yutaka
authors.initials: Y
authors.lastname: Abe
authors.forename: Shiro
authors.initials: S
authors.lastname: Onozawa
authors.forename: Yasushige
authors.initials: Y
authors.lastname: Komada
authors.forename: Yukihiro
authors.initials: Y
authors.lastname: Kondo
authors.forename: Ryoji
authors.initials: R
authors.lastname: Kimata
authors.forename: Seiichiro
authors.initials: S
authors.lastname: Himeno
authors.forename: Mitsuo
authors.initials: M
authors.lastname: Satake
mesh_terms: D000792:Angiography; D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000032:analysis / Q000493:pharmacokinetics; D001775:Blood Circulation; D010478:Chemotherapy, Cancer, Regional Perfusion / Q000379:methods*; D008297:Male; D008954:Models, Biological; D010388:Pelvis / Q000098:blood supply*; D010984:Platinum / Q000008:administration & dosage* / Q000032:analysis / Q000493:pharmacokinetics; D012039:Regional Blood Flow; D013552:Swine
chemical_list: D000970:Antineoplastic Agents; D010984:Platinum